Hyderabad: TSMC Turns Up The Heat On Quacks

Hyderabad: A series of raids on quacks in recent weeks have revealed how easily they have been able to run hospitals with 10-20 beds where even MBBS doctors were employed. The Telangana State Medical Council (TSMC) is trying to break the quacks’ nexus with doctors and hospitals which give them kickbacks for referring patients.

While bigger hospitals have distanced themselves following the frequent raids, smaller ones continue to be hand in glove with these quacks, especially in rural areas.

For quacks, any kind of partnership — be it from the  medical/equipment supply chain or hospital setups with laboratories — works in their favour as they get 20-50% cut for referrals, enabling them to expand their business.

“In many rural areas quacks are running 20-bed hospitals, employing 5-12 employees. These may be qualified nurses or doctors or fake ones. In certain cases we have seen that the entire staff is unqualified even though they claim to be MBBS doctors and trained nurses,” said TSMC vice chairman Dr G Srinivas.

“We are holding a lot of awareness drives which has curbed the nexus between quacks and hospitals to some extent, but it may still be there in rural areas. Whenever a new hospital or clinic is set up, quacks demand a cut.

This is on the decline, but we are working on it,” Srinivas said.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre